Effects of the Selective Sodium-Glucose Cotransporter 2 Inhibitor Empagliflozin on Vascular Function and Central Hemodynamics in Patients With Type 2 Diabetes Mellitus.
暂无分享,去创建一个
R. Schmieder | D. Kannenkeril | C. Ott | K. Striepe | Markus P Schneider | M. Karg | A. Jumar | Markus P. Schneider | Markus P. Schneider